CAPITOL HILL CONSULTING GROUP for ASTELLAS PHARMA US
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 9, 2008 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Jul 16, 2008 | $30,000 | Replaced |
| 2nd Quarter - Amendment | Dec 10, 2009 | $30,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
Pharmaceutical and life sciences, including but not limited to: coverage and reimbursement issues under the Medicare and Medicaid programs
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER New | — |
| AMANDA HILL | — |
| STEVEN E IRIZARRY | — |
Pharmacy PHA
Pharmaceutical and life sciences, including but not limited to: The Federal Food, Drug and Cosmetic Act; the Hatch-Waxman Act; drug importation; and drug safety
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER New | — |
| AMANDA HILL | — |
| STEVEN E IRIZARRY | — |
Health Issues HCR
Pharmaceutical and life sciences, including but not limited to, federal organ transplant and anti-infectives policy
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL K BREWSTER New | — |
| AMANDA HILL | — |
| STEVEN E IRIZARRY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.